Oxigene And Azanta Danmark A/s Have Established A Partnership Agreement To Provide Access To Zybrestat For The Treatment Of Patients In Europe And Canada With Anaplastic Thyroid Cancer (Atc) On A Compassionate Use Basis.
SOUTH SAN FRANCISCO, - OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, and A ...
Satisfied Users & 
Approved Press Releases
